Staff turnover in EUR1,051,2811,048,7481,172,0681,389,8631,343,870
Staff turnover in EUR1,051,2811,048,7481,172,0681,389,8631,343,870
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)12.9913.0913.1012.4013.32
Dividend per share-----
Basic earnings per share-0.581.020.876.423.29
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover148.1147.8157.6208.5232.4
Operating income (EBIT)4.624.926.669.152.4
Earnings before taxes-6.812.110.560.345.9
Annual net profit/ loss-6.812.110.577.640.2
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets241.1175.4152.1220.9251.7
Total fixed assets6.245.521.136.930.3
Total assets247.3220.8173.3257.8282.0
Liabilities
Total short-term liabilities174.474.847.645.649.2
Total long-term liabilities131.5166.7135.7131.2104.8
Total provisions25.08.315.110.28.2
Equity capital-58.6-20.7-10.081.0127.9
Total liabilities247.3220.8173.3257.8282.0
Management:
David Veitch
Gerrit Hauck
Laurenz Kellenberger
Marc Engelhardt
Adesh Kaul
Damian Heller
Ph.D. Mark Jones
Ph.D. Peter Bielmeier
Raimond Grewenig-Scheurich
Ursula Eberhardt
Board:
Alf Gunnar Martin Nicklasson
Carole Sable
Nicole Onetto
Thomas Werner
Leonard Kruimer
Stephan Schindler
Shareholding in %:
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 2.49
American Century Investment Management, Inc. 1.99
Basilea Pharmaceutica AG 7.63
Black Creek Investment Management, Inc. 2.96
BlackRock Fund Advisors 2.64
Dimensional Fund Advisors LP 1.01
UBS Asset Management Switzerland AG 4.99
Valiant Bank AG 0.82
Vanguard Capital Management LLC 2.88
Zürcher Kantonalbank (Investment Management) 2.41
Freefloat 70.18
Address: Hegenheimermattweg 167b, 4123 Allschwil
T: +41-61-606-11-11
F: +
I: http://www.basilea.com
E: [email protected]